

Inspired by Nature.
Empowered by Technology.
Committed to Life.
Advancing Human-Relevant Systems to Reduce Reliance on Animal Models
Integrated • Predictive • Translational
Accelerating Smarter, More Human-Relevant Medicine

Foundational Translational Program
Human-Relevant Functional Testing for Research & Drug Development
Functional Biology for Smarter R&D Decisions
A human-relevant platform generating functional insight from complex biological systems: beyond static models.
Key Value Points
-
Human-relevant 3D and dynamic model systems
-
Functional response profiling under controlled conditions
-
Scalable entry into advanced translational workflows
Scientific Rationale — Beyond Genomics
Precision oncology is entering a critical phase of transformation.
Over the past decade, genomic profiling has redefined how cancer is understood, enabling the identification of targetable alterations and informing therapeutic strategies. Yet, despite these advances, outcomes remain variable.
A substantial proportion of patients derive limited benefit from genomics-guided approaches, highlighting a fundamental gap: tumour behaviour is not dictated solely by genetic alterations, but also by dynamic, non-genetic mechanisms that shape therapeutic response in real time.
This limitation has driven the emergence of Functional Precision Oncology (FPO), a paradigm shift in which therapeutic strategies are informed not only by what a tumour is, but by how it behaves under controlled experimental perturbations.
FPO is based on direct functional testing of therapeutic agents in biologically relevant tumour models, enabling the identification of:
-
Context-dependent drug responses,
-
Resistance mechanisms,
-
Potentially effective therapeutic combinations.
By capturing the functional state of cancer systems, this approach provides a dynamic layer of insight that complements genomic and molecular profiling.
How NAMina Enables Functional Precision Oncology
NAMina Bio translates the principles of Functional Precision Oncology into a scalable, research-focused platform.
Rather than operating in the clinical or diagnostic space, NAMina provides:
-
Controlled experimental systems for functional testing
-
Standardised workflows for reproducible data generation
-
Integrated data interpretation frameworks
Our platform enables partners to:
-
Investigate biological response to perturbations
-
Generate high-value functional datasets
-
Support translational research and therapeutic development
All outputs are designed for research and preclinical use, supporting scientific and R&D decision-making.
Positioning
NAMina operates at the intersection of:
Functional biology
Advanced in vitro modelling
Data-driven interpretation
We contribute a functional layer of biological understanding, designed to complement existing genomic and molecular approaches, without replacing clinical evaluation or diagnostic processes.


From Experimental Design to Functional Insight
The Foundational Translational Program provides a structured entry into human‑relevant experimental systems, enabling reproducible functional datasets that support early‑stage research and therapeutic development.
We support:
-
Functional response profiling (drug sensitivity, phenotypic shufts)
-
Comparative evaluation across compounds or conditions
-
Early prioritisation of therapeutic strategies
-
Generation of structured datasets for downstream analysis
This program bridges the gap between conventional in‑vitro assays and advanced translational systems.




Bring Functional Biology into Your R&D Workflow
This service represents the first operational layer of the NAMina Translational Architecture Network.
It enables partners to access human-relevant experimental systems without the need to build internal infrastructure, while maintaining flexibility to scale into more advanced translational programs.
Start with a pilot program and access a new generation of human-relevant experimental systems.